Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhefeng Liu

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2022
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b StudyYuankai Shi, Shiman Wu, Ke Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 10, 2023
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studiesSheng Yang, Shiman Wu, Yanqiu Zhao, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Journal of Thoracic Disease|May 22, 2025
Expert consensus on cancer treatment-related lung injuryXinqing Lin, Hui Guo, Wei Zhao, et al.
Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.
Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.
Thoracic Cancer|November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancerDingzhi Huang, Gen Lin, Qian Chu, et al.
Translational Lung Cancer Research|September 11, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary diseaseChengzhi Zhou, Yinyin Qin, Wei Zhao, et al.
Thoracic Cancer|July 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesotheliomaQian Wang, Chunwei Xu, Wenxian Wang, et al.
Cancer Biology & Medicine|April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationHuijing Feng, Yang Xia, Wenxian Wang, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2022
Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b StudyYuankai Shi, Shiman Wu, Ke Wang, et al.
Lung Cancer (Amsterdam, Netherlands)|May 10, 2023
Central nervous system efficacy of rezivertinib (BPI-7711) in advanced NSCLC patients with EGFR T790M mutation: A pooled analysis of two clinical studiesSheng Yang, Shiman Wu, Yanqiu Zhao, et al.
Thoracic Cancer|November 29, 2022
Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancerShirong Zhang, Wenxian Wang, Chunwei Xu, et al.
Journal of Thoracic Disease|May 22, 2025
Expert consensus on cancer treatment-related lung injuryXinqing Lin, Hui Guo, Wei Zhao, et al.
Thoracic Cancer|January 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancerGen Lin, Zhijie Wang, Qian Chu, et al.
Thoracic Cancer|September 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in ChinaXingxiang Pu, Chunwei Xu, Qian Wang, et al.
Thoracic Cancer|November 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancerDingzhi Huang, Gen Lin, Qian Chu, et al.
Translational Lung Cancer Research|September 11, 2023
International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary diseaseChengzhi Zhou, Yinyin Qin, Wei Zhao, et al.
Thoracic Cancer|July 17, 2023
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesotheliomaQian Wang, Chunwei Xu, Wenxian Wang, et al.
Cancer Biology & Medicine|April 9, 2025
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alterationHuijing Feng, Yang Xia, Wenxian Wang, et al.
Pageof 6